Acciones DECHRA PHARMACEUTICALS LIMITED OTC Markets
Acciones
DPHAY
US2434351043
Ventas 2022 | 682 M 884 M 811 M | Ventas 2023 | 762 M 988 M 906 M | Capitalización | 4197,92 M 5445,5 M 4995,48 M |
---|---|---|---|---|---|
Resultado Neto 2022 | 58 M 75,24 M 69,02 M | Resultado Neto 2023 | -27 M -35,02 M -32,13 M | VE / Ventas 2022 | 5,8 x |
Deuda neta 2022 | 208 M 270 M 248 M | Deuda neta 2023 | 430 M 558 M 512 M | VE / Ventas 2023 | 6,08 x |
P/E ratio 2022 |
64,8
x | P/E ratio 2023 |
-150
x | Empleados | - |
Rendimiento 2022 |
1,3 % | Rendimiento 2023 |
0,34 % | Flotante | 0 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ian Page
CEO | Chief Executive Officer | 63 | 13/06/97 |
Paul Sandland
DFI | Director of Finance/CFO | 44 | 01/01/10 |
Jamie Adams
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ian Page
CEO | Chief Executive Officer | 63 | 13/06/97 |
Alison Platt
CHM | Chairman | - | 01/03/20 |
John Shipsey
BRD | Director/Board Member | - | 01/06/22 |